4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-022480
Chief Operating Officer sold 857 shares at $2.23 ($1,911)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2023-06-15 | Sale | −857 | $2.23 | $1,911 | 151,857 | D |
| Open-market sales · 857 sh · avg $2.23 · $1,911 | |||||||
Loading xslF345X04/wk-form4_1686947049.xml…